Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS
- 24 January 2020
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 73 (9) , 571-577
Abstract
Aims: The aim of this study was to describe the characteristics of the bone marrow infiltration found in a series of clinically defined lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinaemia (WM) and IgM-monoclonal gammopathy of undetermined significance (MGUS) and to perform a targeted next-generation sequencing (NGS) for the identification of additional somatic mutations to MYD88 p.L265P in LPL/WM. Methods: We have reviewed a series of 35 bone marrow biopsies from 28 patients with a clinical diagnosis of LPL/WM (24 cases) or MGUS (4 cases). Bone marrow infiltration characteristics by morphology, immunohistochemistry, flow cytometry (FCM), allele-specific real-time PCR for the detection of MYD88 p.L265P mutation, targeted exonic amplicon-based NGS of 35 lymphoma-related genes and direct sequencing were analysed. Results: Our findings show that bone marrow trephine biopsy evaluation is superior to FCM in the identification of significant lymphoid infiltrates. A combined paratrabecular and interstitial infiltration pattern is the most common feature in LPL/WM while a patchy interstitial pattern characterises IgM-MGUS cases. MYD88 p.L265P mutation was found by allele-specific-PCR in 92% of the LPL cases (22 out of 24) and 25% of IgM-MGUS cases (1 out of 4 cases). In addition to MYD88 p.L265P somatic mutations in CXCR4 , KMT2D , PRDM1 /Blimp1, MYC and ID3 were found by NGS and direct sequencing in 4 cases. Conclusions: In conclusion, bone marrow core biopsy evaluation is critical in the identification of unequivocal bone marrow infiltration by LPL/WM. In addition to MYD88 p.L265P, somatic mutations in CXCR4 , KMT2D , PRDM1 /Blimp1, MYC and ID3 can appear in a fraction of LPL/WM.Keywords
Funding Information
- Instituto de Salud Carlos III (PI16/01397)
This publication has 25 references indexed in Scilit:
- Defining Lymphoplasmacytic LymphomaAmerican Journal of Clinical Pathology, 2018
- Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemiaBlood, 2016
- Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström MacroglobulinaemiaBritish Journal of Haematology, 2016
- Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May HarborMYD88L265P MutationsAmerican Journal of Clinical Pathology, 2016
- Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma in the Bone MarrowAmerican Journal of Clinical Pathology, 2015
- Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenström macroglobulinemiaBlood, 2014
- The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesisBlood, 2014
- MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reactionBlood, 2013
- MYD88 L265P Somatic Mutation in Waldenström's MacroglobulinemiaNew England Journal of Medicine, 2012
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003